Pre-clinical and retrospective studies suggest that statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), used to treat cardiovascular diseases, can have anti-cancer activity in different tumoral contexts, including OC [72,73,74,75]. The gene discussed is HMGCR; the disease is cardiovascular disorder.